Moderna Inc (MRNA): Congress and insider trades

Who in Congress and inside the company traded MRNA, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Moderna Inc (MRNA) is a listed stock on NASDAQ.
  • 6 members of Congress filed 28 buys and 31 sells of MRNA, the latest published 2026-09-10 (10 September 2026).
  • Insiders filed 0 open market buys worth $0 and 7 sells worth $38M, the latest filed 2026-09-14 (14 September 2026).
  • Across 17 scored buys, Congress averaged -14.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 24% of them ahead of the index. That result is clearly below the market.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 28 6 members
Congress sells 31
Insider buys 0 $0
Insider sells 7 $38M
Congress buys vs S&P, 90d -14.9% 17 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in MRNA

as of 2026-09-10
  1. Ro Khanna41 trades
  2. Marie Newman7 trades
  3. Josh Gottheimer5 trades
  4. Daniel S. Goldman3 trades
  5. Maria Elvira Salazar2 trades
  6. Rob Bresnahan1 trade
Congress trades in MRNA, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
10 Sep 2026 Maria Elvira Salazar (R-FL) buy 1K–15K 21 n/a
10 Sep 2026 Maria Elvira Salazar (R-FL) sell 1K–15K 21 n/a
7 Sep 2026 Ro Khanna (D-CA) buy 1K–15K 11 n/a
7 Sep 2026 Ro Khanna (D-CA) sell 1K–15K 32 n/a
8 Jul 2026 Ro Khanna (D-CA) buy 1K–15K 6 n/a
11 Jun 2026 Ro Khanna (D-CA) sell 1K–15K 25 n/a
11 Jun 2026 Ro Khanna (D-CA) sell 1K–15K 39 n/a
13 May 2026 Ro Khanna (D-CA) buy 1K–15K 28 +23.7%
15 May 2025 Ro Khanna (D-CA) sell 1K–15K 32 n/a
9 May 2025 Rob Bresnahan (R-PA) sell 1K–15K 30 n/a
10 Nov 2023 Ro Khanna (D-CA) sell 1K–15K 37 n/a
16 Oct 2023 Josh Gottheimer (D-NJ) sell 1K–15K 30 n/a
7 Sep 2023 Ro Khanna (D-CA) buy 1K–15K 8 -28.9%
7 Sep 2023 Ro Khanna (D-CA) buy 1K–15K 34 -28.9%
14 Aug 2023 Daniel S. Goldman (D-NY) sell 50K–100K 32 n/a
9 Aug 2023 Ro Khanna (D-CA) sell 1K–15K 10 n/a
12 Jul 2023 Ro Khanna (D-CA) sell 1K–15K 12 n/a
14 Jun 2023 Ro Khanna (D-CA) buy 1K–15K 20 -17.7%
14 Jun 2023 Ro Khanna (D-CA) sell 1K–15K 24 n/a
22 May 2023 Daniel S. Goldman (D-NY) buy 50K–100K 39 -25.9%
10 May 2023 Ro Khanna (D-CA) buy 1K–15K 13 -29.3%
20 Apr 2023 Josh Gottheimer (D-NJ) buy 1K–15K 20 -21.5%
17 Apr 2023 Daniel S. Goldman (D-NY) sell 50K–100K 42 n/a
12 Apr 2023 Ro Khanna (D-CA) buy 1K–15K 24 -29.8%
10 Mar 2023 Ro Khanna (D-CA) sell 1K–15K 26 n/a
7 Dec 2022 Ro Khanna (D-CA) sell 1K–15K 34 n/a
12 Oct 2022 Ro Khanna (D-CA) buy 1K–15K 31 +30.0%
9 Sep 2022 Ro Khanna (D-CA) sell 1K–15K 38 n/a
11 Jul 2022 Ro Khanna (D-CA) buy 1K–15K 10 -23.7%
11 Jul 2022 Ro Khanna (D-CA) buy 1K–15K 21 -23.7%
15 Jun 2022 Ro Khanna (D-CA) sell 1K–15K 36 n/a
15 Jun 2022 Ro Khanna (D-CA) buy 1K–15K 38 +7.0%
15 Jun 2022 Ro Khanna (D-CA) sell 1K–15K 31 n/a
12 May 2022 Ro Khanna (D-CA) buy 1K–15K 15 +19.6%
12 May 2022 Ro Khanna (D-CA) buy 1K–15K 23 +19.6%
18 Apr 2022 Josh Gottheimer (D-NJ) sell 1K–15K 32 n/a
11 Mar 2022 Ro Khanna (D-CA) buy 15K–50K 19 -9.1%
11 Mar 2022 Ro Khanna (D-CA) buy 1K–15K 22 -9.1%
9 Feb 2022 Ro Khanna (D-CA) sell 1K–15K 28 n/a
9 Feb 2022 Ro Khanna (D-CA) sell 1K–15K 19 n/a
9 Feb 2022 Ro Khanna (D-CA) sell 15K–50K 18 n/a
10 Jan 2022 Ro Khanna (D-CA) buy 15K–50K 24 -21.7%
10 Jan 2022 Ro Khanna (D-CA) buy 1K–15K 31 -21.7%
8 Dec 2021 Ro Khanna (D-CA) sell 1K–15K 35 n/a
8 Dec 2021 Ro Khanna (D-CA) sell 15K–50K 28 n/a
10 Nov 2021 Ro Khanna (D-CA) buy 1K–15K 33 -26.4%
15 Oct 2021 Ro Khanna (D-CA) buy 1K–15K 16 -43.1%
16 Sep 2021 Ro Khanna (D-CA) buy 1K–15K 40 -40.1%
16 Sep 2021 Ro Khanna (D-CA) buy 15K–50K 29 -40.1%
16 Sep 2021 Ro Khanna (D-CA) buy 1K–15K 30 -40.1%
10 Aug 2021 Josh Gottheimer (D-NJ) sell 1K–15K 18 n/a
22 Apr 2021 Josh Gottheimer (D-NJ) sell 1K–15K 37 n/a
22 Apr 2021 Marie Newman (D-IL) sell 15K–50K 82 n/a
22 Apr 2021 Marie Newman (D-IL) sell 1K–15K 82 n/a
14 Feb 2021 Marie Newman (D-IL) sell 1K–15K 36 n/a
14 Feb 2021 Marie Newman (D-IL) sell 15K–50K 36 n/a
14 Feb 2021 Marie Newman (D-IL) sell 1K–15K 22 n/a
14 Feb 2021 Marie Newman (D-IL) buy 1K–15K 30 -16.4%
14 Feb 2021 Marie Newman (D-IL) buy 1K–15K 22 -16.4%

Insider trades in MRNA

as of 2026-09-14
Open market insider trades in MRNA, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
14 Sep 2026 Mock James M sell 34,836 $134.49 $4.7M n/a
3 Sep 2026 Klinger Shannon Thyme sell 3,471 $139.95 $486K n/a
7 Aug 2026 Bancel Stephane sell 499,246 $57.52 $29M n/a
16 Jul 2026 Hoge Stephen sell 53,336 $67.60 $3.6M n/a
8 Jun 2026 Klinger Shannon Thyme sell 3,471 $50.00 $174K n/a
22 May 2026 AFEYAN NOUBAR sell 9,263 $46.84 $434K n/a
4 May 2026 Hussain Abbas sell 5,682 $46.63 $265K n/a

Frequently asked questions

Who has bought MRNA?

28 Congress buys by 6 members and 0 insider buys are on file. The tables on this page list every one.

Did buying MRNA after a disclosure beat the market?

Across 17 scored buys, Congress averaged -14.9% against the S&P 500 (SPY) over the 90 days after disclosure, with 24% of them ahead of the index. That result is clearly below the market. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.